This episode discusses the economic impact of Ozempic and Wagovi on Denmark's economy, the food industry, and obesity in America. Key topics include the potential effects on major corporations like PepsiCo and McDonald's.
The conversation highlights how these drugs could boost Denmark's economy by 1.7 percent, marking a significant economic shift. The host emphasizes that this story is one of the most underreported of 2023.
Furthermore, the episode addresses the health statistics in America, noting that 40 percent of the population does not suffer from depression or live in poverty, yet a significant portion is classified as obese. This raises questions about the broader implications for the food industry.
The discussion suggests that the widespread use of these drugs could drastically alter consumer behavior, potentially leading to a decline in sales for major food companies.
Ozempic and Wagovi could reshape Denmark's economy and impact major food corporations in America.
This episode stands out for the following:
40% of America does not suffer depression.@ProfGalloway is back! And he says THIS is the most underreported story of 2023.
40% of America is not living in poverty.@ProfGalloway is back! And he says THIS is the most underreported story of 2023.
40% of America is not only overweight, they're obese.@ProfGalloway is back! And he says THIS is the most underreported story of 2023.
This could take McDonald's down 50%.@ProfGalloway is back! And he says THIS is the most underreported story of 2023.
